Skip to main content
. 2022 Nov 14;31(2):88–96. doi: 10.1177/02184923221138504

Table 2.

Inclusion and exclusion criteria for patient enrollment were used for both the experimental and control groups.

Inclusion Exclusion
Age 18–85 y Age < 18 y or > 85 y
American Society of Anesthesia ASA classes 2, 3, 4 Patients with overt congestive heart failure (CHF)
Elective or semi-elective cardiac surgery, coronary artery bypass graft (CABG), cardiac valve repair or replacement via median sternotomy, and cardiopulmonary bypass Emergency cases, for example, aortic dissection Patients on mechanical cardiac support [extracorporeal membrane oxygenator (ECMO) and/or intra-aortic balloon pump (IABP)
Patients with mobility problems
Patients who lack support at home
History of stroke or endocarditis
Preoperative hemoglobin (Hb) < 125 g/L
Body mass index (BMI) > 35
Estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m²
Preoperative ejection fraction (EF) < 35% by echocardiography
Surgery requires deep hypothermic circulatory arrest (DHCA)
Percutaneous interventions such as transcatheter aortic valve implantation (TAVI)
Surgery for a heart transplant
Surgery for ventricular assist device insertion
Abnormal liver function tests: albumin < 30 g/L, AST, ALT > double normal range for both (i.e. > 100 units/L)
Intraoperative variables excluded from the analysis
Aortic cross-clamp (AOX) > 150 min
Cardiopulmonary bypass time (CPB) > 240 min
Inability to close the chest due to (bleeding, hemodynamic instability)
Postoperative need for IABP